Quick Answer
CEL SCI CORP reported Cash and Equivalents of $22.67 million for fiscal year 2022.
CEL SCI CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $22.67M | -37.1% |
| 2021 | $36.06M | +132.5% |
| 2020 | $15.51M | +83.7% |
| 2019 | $8.44M | -18.1% |
| 2018 | $10.31M | +335.1% |
| 2017 | $2.37M | -18.8% |
| 2016 | $2.92M | -49.0% |
| 2015 | $5.73M | -32.7% |
| 2014 | $8.51M | +20359.5% |
| 2013 | $41.6K | -98.9% |
| 2012 | $3.94M | -7.5% |
| 2011 | $4.26M | -84.0% |
| 2010 | $26.57M | -20.9% |
| 2009 | $33.57M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | $5.14M | -81.7% | -48.9% |
| March 31, 2023 | $10.05M | -70.7% | -44.2% |
| December 31, 2022 | $18.02M | -51.4% | -20.5% |
| September 30, 2022 | $22.67M | -37.1% | -19.2% |
| June 30, 2022 | $28.07M | -21.9% | -18.1% |
| March 31, 2022 | $34.28M | +433.1% | -7.6% |
| December 31, 2021 | $37.11M | +69.8% | +2.9% |
| September 30, 2021 | $36.06M | +132.5% | +0.3% |
- CEL SCI CORP showed a decrease of -37.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2022 period, CEL SCI CORP’s cash and equivalents has declined by 32.5% (from $33.57 million to $22.67 million).
- The most recent figure is from CEL SCI CORP’s fiscal year 2022 report (Form 10-K), filed with the SEC on December 27, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: